Jennifer Doudna
Li Ka Shing Chancellor’s Professor of Biomedical Science at University of California, Berkeley
Meet Jennifer Doudna
Along with Emmanuelle Charpentier, a Director at the Max Planck Institute for Infection Biology in Berlin, Doudna played an instrumental role in the development of CRISPR-Cas9. The pair were the first to suggest that the technology could be used for gene editing. For her contribution to the cell and gene field, Doudna was the co-winner of the 2020 Nobel Prize for chemistry. Her current research focuses on RNA-guided gene regulation.